LocateBio

Just 1 week until the British Association of Spine Surgeons (BASS) Conference! Locate Bio is delighted to be able to support this event, and our CEO, John von Benecke, will be speaking at the innovation session on Wednesday morning. We are all very much looking forward to it!

We are excited to announce that our next-generation rhBMP-2 product has been admitted to the FDA breakthrough devices program! shorturl.at/aN037

We are so incredibly proud to announce that we have achieved Investors in People Platinum accreditation! Putting people at the heart of our strategy is how we are unleashing potential across the organisation and how Locate Bio is winning at the cutting edge of science.

Take a look inside Locate Bio Ltd! Our employees give an insight into what it's truly like to work at Locate Bio as we strive to develop best in class products that will relieve suffering and restore quality of life for millions around the world. youtu.be/HSUYoqmzkaQ

We are excited to welcome Locate Bio Ltd (@LocateBio), with CEO John von Benecke, as a Presenting Company at Innovation Summit Dublin 2023. Welcome to #InnovationDublin23!

At Locate Bio, we are bucking the gender trend in STEM, with 80% of our employees female! We will be celebrating International Women and Girls in Science day on the 11th of Feb!

Locate Bio is proud to be part of an incredible industry working hard towards relieving suffering and delivering better outcomes for patients worldwide. youtu.be/G_dfV44J8fk via @YouTube

In our 2nd abstract accepted for presentation at Spineweek 2023, we will be sharing data from our recently completed study of interbody fusion in a skeletally mature ovine model. Exciting results from Locate's proprietary #ProgrammedDrugRelease of #BMP2 tinyurl.com/2mzvfn67

We are very pleased to have not just 1 but 2 abstracts accepted for presentation at Spineweek 2023! CertOss Conduit showed clear new bone formation at just 6 weeks when implanted intramuscularly, with strong bone growth progressing through to 12 weeks. tinyurl.com/mr3dvdb8

5. @LocateBio, John von Benecke, CEO → Locate Bio provides surgeons with next-generation orthobiologics so they can relieve suffering and restore quality of life for the 1.7 billion people around the globe who suffer from muscular-skeletal conditions.

@lsintelligence @adaptiximaging @adaptiximaging Looking forward to seeing you present in March!

4. Adaptix, Mark Evans, CEO → @AdaptixImaging is transforming radiology with an addressable Flat Panel X-ray Source with many individually addressable emitters with integrated power supply – essentially ‘digitizing’ the source to complete the digitization of the imaging system.

5 NEW Presenting Companies have been selected to present at #LSIUSA23 🎉 1. PrecisionOS, Danny Goel, CEO → @PrecisionOSVR brings medical-grade, interactive virtual reality (VR) experiences to surgical training for physicians.

@MedTechStrat @MedTechStrat we’re looking forward to showcasing Locate Bio’s programmed drug release pipeline in Dublin

Is your innovative #medtech startup seeking high-quality, investment/strategic partners from around the globe, specifically Dublin, Ireland? You still have time to apply to showcase your medical device company at Innovation Summit Dublin 2023. ⬇️Expand for more info.

The global population is ageing rapidly. Click the infographic below to see the dramatic country-by-country change between 1950 and 2100. This will have profound implications for global healthcare Global ageing population public.flourish.studio/visualisation/… Visualised with @f_l_o_u_r_i_s_h

🤝 𝙈𝙚𝙚𝙩 𝙩𝙝𝙚 𝙁𝙪𝙣𝙙𝙚𝙧 🤝 We're kicking off 2023's Meet the Funder with Mercia's COO, Peter Dines Peter is responsible for a number of the life science portfolio investments including @LocateBio, @sensedx1 and @medovate Book ⬇️ #MeetTheFunder #Investment #Scale #Seed

Interesting reading from the 2022 SVB Healthcare Investments and Exits Report. A 2-year surge in VC investments into drug delivery companies (early stage 474%, late-stage 300% ). We are excited about how our Programmed Drug Release might achieve breakthroughs in performance.

Our CEO outlining the key societal issues that Locate Bio are actively addressing using Programmed Drug Release linkedin.com/company/locate…

Our CEO John von Benecke provided his perspective at the #LSIEurope22 panel with #MCRA on how the EU regulatory changes have significantly impacted global market entry strategies for start-ups. lnkd.in/e_r9hrTG

@Locate Bio is attending @Phacilitate's Advanced Therapies Week conference in Miami this week, after being named as one of their Top 20 companies to watch. #CellTherapy #GeneTherapy

@LocateBio senior management will be available for investor and partnering meetings at the #biotechshowcase in San Francisco, 13-15 January 2020.

@LocateBio named one of the Top 20 Advanced Therapy biotechs to watch in 2020, curated with input from industry nominations and @Phacilitate. phacilitate.co.uk/article/top-20…